• 2022
  Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, Duru C, Koffi AD, Castelain S, Fernandes-Pellerin S, Jolly N, De Facci LP, Roux E, Ungeheuer MN, Van Der Werf S, White M, Schwartz O, Fontanet A, , Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
• 2022
  Garcia L, Woudenberg T, Rosado J, Dyer AH, Donnadieu F, Planas D, Bruel T, Schwartz O, Prazuck T, Velay A, Fafi-Kremer S, Batten I, Reddy C, Connolly E, McElheron M, Kennelly SP, Bourke NM, White MT, Pelleau S, , Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
• 2021
  Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M, , Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 11; 224(9): 1489-1499.
• 2021
  de Thoisy B, Duron O, Epelboin L, Musset L, Quénel P, Roche B, Binetruy F, Briolant S, Carvalho L, Chavy A, Couppié P, Demar M, Douine M, Dusfour I, Epelboin Y, Flamand C, Franc A, Ginouvès M, Gourbière S, Houël E, Kocher A, Lavergne A, Le Turnier P, Mathieu L, Murienne J, Nacher M, Pelleau S, Prévot G, Rousset D, Roux E, Schaub R, Talaga S, Thill P, Tirera S, Guégan JF, , Ecology, evolution, and epidemiology of zoonotic and vector-borne infectious diseases in French Guiana: Transdisciplinarity does matter to tackle new emerging threats., Infect Genet Evol 2021 09; 93(): 104916.
• 2021
  Rodero MP, Pelleau S, Welfringer-Morin A, , Duffy D, Melki I, Bader-Meunier B, , , Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection., J Clin Immunol 2021 Aug; (): .
• 2021
  Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M, , Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
• 2021
  Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T, , Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 05; 2(5): 100275.
• 2021
  Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, Meola A, Kerneis S, Terrier B, Fafi-Kremer S, de Seze J, Bruel T, Dejardin F, Petres S, Longley R, Fontanet A, Backovic M, Mueller I, White MT, , Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
• 2020
  Mosnier E, Roux E, Cropet C, Lazrek Y, Moriceau O, Gaillet M, Mathieu L, Nacher M, Demar M, Odonne G, Douine M, Michaud C, Pelleau S, Djossou F, Musset L, , Prevalence of Plasmodium spp. in the Amazonian Border Context (French Guiana-Brazil): Associated Factors and Spatial Distribution., Am J Trop Med Hyg 2020 01; 102(1): 130-141.
• 2019
  Musset L, Heugas C, Naldjinan R, Blanchet D, Houze P, Abboud P, Volney B, Walter G, Lazrek Y, Epelboin L, Pelleau S, Ringwald P, Legrand E, Demar M, Djossou F, , Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana., Antimicrob Agents Chemother 2019 11; 63(11): .
• 2018
  Douine M, Lazrek Y, Blanchet D, Pelleau S, Chanlin R, Corlin F, Hureau L, Volney B, Hiwat H, Vreden S, Djossou F, Demar M, Nacher M, Musset L, , Predictors of antimalarial self-medication in illegal gold miners in French Guiana: a pathway towards artemisinin resistance., J Antimicrob Chemother 2018 Jan; 73(1): 231-239.
• 2017
  Mosnier E, Douine M, Epelboin L, Pelleau S, Pommier de Santi V, Dangel Y, Demar M, Mutricy R, Guarmit B, Nacher M, Brousse P, Davy D, Djossou F, Musset L, , Asymptomatic Plasmodium falciparum and vivax infection in the neighborhood of Blondin, Saint-Georges-de-l’Oyapock District, French Guiana., Bull Soc Pathol Exot 2017 Oct; 110(4): 265-269.
• 2017
  Leba LJ, Popovici J, Estevez Y, Pelleau S, Legrand E, Musset L, Duplais C, , Antiplasmodial activities of dyes against Plasmodium falciparum asexual and sexual stages: Contrasted uptakes of triarylmethanes Brilliant green, Green S (E142), and Patent Blue V (E131) by erythrocytes., Int J Parasitol Drugs Drug Resist 2017 12; 7(3): 314-320.
• 2016
  Faway E, Musset L, Pelleau S, Volney B, Casteras J, Caro V, Menard D, Briolant S, Legrand E, , Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana., Malar J 2016 Nov; 15(1): 540.
• 2016
  Douine M, Musset L, Corlin F, Pelleau S, Pasquier J, Mutricy L, Adenis A, Djossou F, Brousse P, Perotti F, Hiwat H, Vreden S, Demar M, Nacher M, , Prevalence of Plasmodium spp. in illegal gold miners in French Guiana in 2015: a hidden but critical malaria reservoir., Malar J 2016 06; 15(): 315.
• 2016
  Pommier de Santi V, Djossou F, Barthes N, Bogreau H, Hyvert G, Nguyen C, Pelleau S, Legrand E, Musset L, Nacher M, Briolant S, , Malaria Hyperendemicity and Risk for Artemisinin Resistance among Illegal Gold Miners, French Guiana., Emerg Infect Dis 2016 May; 22(5): 903-6.
• 2015
  Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, Volkman SK, Wirth DF, Legrand E, Fidock DA, Neafsey DE, Musset L, , Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt., Proc Natl Acad Sci U S A 2015 Sep; 112(37): 11672-7.
• 2015
  Mura M, Briolant S, Donato D, Volney B, Pelleau S, Musset L, Legrand E, , Absence of correlation between ex vivo susceptibility to doxycycline and pfteQ-pfmdt gene polymorphism in French Guiana., Malar J 2015 Jul; 14(): 286.
• 2015
  Leba LJ, Musset L, Pelleau S, Estevez Y, Birer C, Briolant S, Witkowski B, Ménard D, Delves MJ, Legrand E, Duplais C, Popovici J, , Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay., Malar J 2015 Jun; 14(): 234.
• 2014
  Musset L, Pelleau S, Girod R, Ardillon V, Carvalho L, Dusfour I, Gomes MS, Djossou F, Legrand E, , Malaria on the Guiana Shield: a review of the situation in French Guiana., Mem Inst Oswaldo Cruz 2014 Aug; 109(5): 525-33.
• 2012
  Pelleau S, Diop S, Dia Badiane M, Vitte J, Beguin P, Nato F, Diop BM, Bongrand P, Parzy D, Jambou R, , Enhanced basophil reactivities during severe malaria and their relationship with the Plasmodium falciparum histamine-releasing factor translationally controlled tumor protein., Infect Immun 2012 Aug; 80(8): 2963-70.
• 2012
  Razakandrainibe R, Pelleau S, Grau GE, Jambou R, , Antigen presentation by endothelial cells: what role in the pathophysiology of malaria?, Trends Parasitol 2012 Apr; 28(4): 151-60.
• 2011
  Pelleau S, Bertaux L, Briolant S, Ferdig MT, Sinou V, Pradines B, Parzy D, Jambou R, , Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum., Antimicrob Agents Chemother 2011 Dec; 55(12): 5834-41.
• 2011
  Sinou V, Quang le H, Pelleau S, Huong VN, Huong NT, Tai le M, Bertaux L, Desbordes M, Latour C, Long LQ, Thanh NX, Parzy D, , Polymorphism of Plasmodium falciparum Na(+)/H(+) exchanger is indicative of a low in vitro quinine susceptibility in isolates from Viet Nam., Malar J 2011 Jun; 10(): 164.
• 2011
  Briolant S, Pelleau S, Bogreau H, Hovette P, Zettor A, Castello J, Baret E, Amalvict R, Rogier C, Pradines B, , In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo., Malar J 2011 Feb; 10(): 37.
• 2009
  Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, Baret E, Mosnier J, Amalvict R, Fusai T, Rogier C, Pradines B, , Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine., Antimicrob Agents Chemother 2009 May; 53(5): 1926-30.
• 2006
  Migot-Nabias F, Pelleau S, Watier L, Guitard J, Toly C, De Araujo C, Ngom MI, Chevillard C, Gaye O, Garcia A, , Red blood cell polymorphisms in relation to Plasmodium falciparum asymptomatic parasite densities and morbidity in Senegal., Microbes Infect 2006 Aug; 8(9-10): 2352-8.
• 2006
  Sarr JB, Pelleau S, Toly C, Guitard J, Konaté L, Deloron P, Garcia A, Migot-Nabias F, , Impact of red blood cell polymorphisms on the antibody response to Plasmodium falciparum in Senegal., Microbes Infect 2006 Apr; 8(5): 1260-8.
• 2006
  De Araujo C, Migot-Nabias F, Guitard J, Pelleau S, Vulliamy T, Ducrocq R, , The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal., Haematologica 2006 Feb; 91(2): 262-3.